Safety, Tolerability and Pharmacokinetics (PK) of RV1162 in Healthy Subjects and COPD Patients

Clinical trial NCT01970618 · COMPLETED

Trial details

NCT number: NCT01970618
Sponsor: Respivert Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)Healthy Volunteers

Start date: 2013-10-01
Primary completion: 2014-11-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.